DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1Dr.Reddy's Laboratories Ltd
03 1Apicore US LLC
04 1Aurobindo Pharma Limited
05 1Biocon Limited
06 1Cambrex Charles City, Inc
07 1Celgene Chemicals Sarl
08 1Changzhou Pharmaceutical Factory
09 2Cipla Ltd.
10 1Hetero Labs Limited
11 2Lonza AG
12 2MSN Laboratories Private Limited
13 1MYLAN LABORATORIES LIMITED
14 2VALARY LAB PRIVATE LIMITED
15 1Viyash Life Sciences Private Limited
01 5LENALIDOMIDE
02 1LENALIDOMIDE (Form-H1)
03 1LENALIDOMIDE HEMIHYDRATE (FORM-B)
04 11Lenalidomide
05 1Lenalidomide Dimethyl Sulphoxide
01 1China
02 11India
03 5U.S.A
04 2Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-911
Start Marketing Date : 2015-11-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-026
Start Marketing Date : 2020-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14096-131
Start Marketing Date : 2008-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55488-0700
Start Marketing Date : 2021-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7720
Start Marketing Date : 2016-09-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7726
Start Marketing Date : 2021-02-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49187-0750
Start Marketing Date : 2023-08-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49187-0751
Start Marketing Date : 2023-08-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0061
Start Marketing Date : 2017-03-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0065
Start Marketing Date : 2017-09-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Revlimid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Revlimid, including repackagers and relabelers. The FDA regulates Revlimid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Revlimid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Revlimid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Revlimid supplier is an individual or a company that provides Revlimid active pharmaceutical ingredient (API) or Revlimid finished formulations upon request. The Revlimid suppliers may include Revlimid API manufacturers, exporters, distributors and traders.
click here to find a list of Revlimid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Revlimid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Revlimid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Revlimid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Revlimid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Revlimid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Revlimid suppliers with NDC on PharmaCompass.
We have 13 companies offering Revlimid
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
